LDS/Medical Tests/Cancer Antigen (CA) 72-4

Cancer Antigen (CA) 72-4

Cancer Antigens are also called tumor markers, which can aid in the diagnosis and monitoring of patients with various cancers. Cancer Antigen 72-4 (CA 72-4) also known as Tumor-associated glycoprotein 72 (TAG-72) is increased in several cancer types including pancreas, stomach, gallbladder, biliary tract, colon, breast, ovary, cervix, and endometrium. The highest values for CA 72-4 are most closely related to gastrointestinal cancer and ovarian cancer. CA 72-4 can also be associated with non-cancerous disease such as Rheumatic disease and ovary cysts. While gastrointestinal cancer has been in a decline in the U.S., these cancers have high prevalence in Iceland, Japan, and Chile. CA 72-4 is used in conjunction with CA 19-9 and CEA assays to diagnose and monitor gastrointestinal cancer patients. CA 72-4 can also be used to help identify the stage of gastrointestinal cancer due to a good correlation with the CA72-4 levels and the stage of the cancer. CA 72-4 can be used as a monitoring assay for patients with ovarian cancer. This is most appropriate for those patients that have negative results for CA 125 (which is typically used to monitor ovarian cancer).

  • Monitoring therapy and detect recurrences of gastrointestinal cancer, including gastric carcinoma.
  • In conjunction with other cancer antigens used in monitoring ovarian cancer
  • Can be increased in multiple cancer types such as Stomach Cancer, Gallbladder Cancer, Breast Cancer, Ovarian Cancer and Cervical Cancer
  • Iincreasing levels with tumor progression
  • Decreasing in therapeutic response

0 - 3.5 U/mL

 

 

Enzyme Immunoassay, Chemiluminescence immunoassay (CLIA)

Serum (SST) or Plasma

Stability

  • Ambient: 8 hours
  • Refrigerated: 1 week
  • Frozen: 1 year
CEA, CA19-9, EGFR/KRAS/BRAF mutation analysis, microsatellite instability, mismatch repair genetic mutation testing by molecular method or by IHC, CA 15-3, CA 27-29, CA 125 and occult blood.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Cancer Res. 1988 Dec 1;48(23):6811-8. [PMID: 3180090]
  • Oncology. 2004;66(2):126-31. [PMID: 15138364]
  • Int J Rad Appl Instrum B. 1991;18(4):395-401. [PMID: 1864728]
  • Dis Markers. 2000;16(3-4):105-10. [PMID: 11381189]
  • Louise M. Immunology & Serology in Laboratory Medicine. St. Louis, MO: Mosby Elsevier Health Science (1996)